Internal Medicine · New York, NY
NPI
1710440151
Since 2019
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
350 E 17th St Fl 20
New York, NY, 10003
Phone (443) 802-2223
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.4M
2,345 prescriptions
Company payments, 2025
$3,602
From 19 companies
Medicare prescription drug claims, 2024
In 2024, the drug Nathanael Kim prescribed most often to Medicare patients was Atorvastatin Calcium, with 175 prescriptions and refills. In total Nathanael Kim wrote 2,345 Medicare prescriptions that cost $1.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 175 | 432 | 49 | $1,326 |
| Amlodipine Besylate Generic | 135 | 315 | 39 | $681 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 105 | 131 | 17 | $518K |
| Lisinopril Generic | 93 | 231 | 25 | $497 |
| Valacyclovir Valacyclovir Hcl | 74 | 92 | 14 | $2,211 |
| Rosuvastatin Calcium Generic | 73 | 179 | 24 | $427 |
| Losartan Potassium Generic | 66 | 160 | 18 | $270 |
| Zolpidem Tartrate Generic | 64 | 64 | 16 | $376 |
| Metformin Hcl Er Metformin Hcl | 50 | 80 | Under 11 | $272 |
| Descovy Emtricitabine/Tenofov Alafenam | 50 | 50 | Under 11 | $109K |
| Escitalopram Oxalate Generic | 47 | 65 | Under 11 | $483 |
| Levothyroxine Sodium Generic | 45 | 100 | 14 | $188 |
| Bupropion Xl Bupropion Hcl | 38 | 50 | Under 11 | $438 |
| Omeprazole Generic | 37 | 57 | Under 11 | $208 |
| Tamsulosin Hcl Generic | 32 | 80 | 11 | $374 |
Brand drugs: 503 claims; generic drugs: 1,842 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nathanael Kim $3,602 ($3,602 in general payments such as food, travel and fees) from 19 companies. The largest payer was ViiV Healthcare Company with $1,514.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 76 | $1,514 |
| Gilead Sciences, Inc. GILD | 25 | $531 |
| Abbvie Inc. ABBV | 21 | $347 |
| Merck Sharp & Dohme LLC MRK | 10 | $280 |
| Shionogi Inc 4507.T | 6 | $159 |
| Lundbeck LLC | 4 | $113 |
| Vanda Pharmaceuticals Inc. VNDA | 4 | $103 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $77.57 |
| Pfizer Inc. PFE | 3 | $75.97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $72.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.